Shares of Quest Diagnostics Inc. DGX slid 1.11% to $173.46 Wednesday, on what proved to be an all-around mixed trading ...

Quest Diagnostics will take over the kidney-focused lab testing portfolio of the dialysis giant Fresenius Medical ...

DGX stays on investors' radars due to its robust prospects in Advanced Diagnostics and progress in the acquisition strategy.

Fresenius Medical Care plans to sell select assets of Spectra Laboratories to Quest Diagnostics as it exits non-core markets.

The acquisition will add dialysis-related water testing to Quest’s portfolio and position the company to perform the tests ...

This was the stock's seventh consecutive day of gains.

Quest Diagnostics Incorporated (DGX), headquartered in Secaucus, New Jersey, offers diagnostic testing and services globally.

Fresenius Medical (FMS) and Quest Diagnostics (DGX) announced that, under terms of a definitive acquisition agreement, Quest will acquire select ...

Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Guggenheim analyst Subbu Nambi noted that Grail (GRAL) announced a partnership yesterday with Quest Diagnostics (DGX) to offer Galleri, ...